Luc Montagnier | Academic Influence

Luc Montagnier's AcademicInfluence.com Rankings

Luc Montagnier

Biology

#43

World Rank

#82

Historical Rank

Virology

#4

World Rank

#4

Historical Rank

Immunology

#37

World Rank

#41

Historical Rank

biology Degrees

Luc Montagnier

Philosophy

#1764

World Rank

#2843

Historical Rank

Logic

#1356

World Rank

#1977

Historical Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Luc Montagnier's Degrees

Doctorate Medicine Université Paris Cité

Why Is Luc Montagnier Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Luc Montagnier was a French virologist and joint recipient, with and , of the 2008 Nobel Prize in Physiology or Medicine for his discovery of the human immunodeficiency virus . He worked as a researcher at the Pasteur Institute in Paris and as a full-time professor at Shanghai Jiao Tong University in China.

(See a Problem?)

Luc Montagnier's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). (1983) (6417)
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV (1984) (2406)
AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS. (1964) (1251)
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap (2000) (894)
Genome organization and transactivation of the human immunodeficiency virus type 2 (1987) (818)
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983. (2004) (519)
HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product (1987) (509)
Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. (1996) (509)
Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients (1986) (485)
Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. (1991) (410)
The cytopathic effect of HIV is associated with apoptosis. (1991) (381)
Human immunodeficiency viruses. (1986) (346)
Programmed cell death in AIDS-related HIV and SIV infections. (1993) (327)
Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. (1984) (325)
Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. (1987) (322)
Molecular cloning and polymorphism of the human immune deficiency virus type 2 (1986) (304)
Lifestyle-related factors and environmental agents causing cancer: an overview. (2007) (302)
Simian Immunodeficiency Virus Replicates to High Levels in Sooty Mangabeys without Inducing Disease (1998) (298)
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene (1998) (295)
Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences (2009) (292)
Apoptosis in AIDS. (1993) (288)
INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHT (1985) (276)
The discovery of HIV as the cause of AIDS. (2003) (276)
Single amino-acid changes in HIV envelope affect viral tropism and receptor binding (1989) (269)
What to call the AIDS virus? (1986) (262)
INACTIVATION OF LYMPHADENOPATHY ASSOCIATED VIRUS BY CHEMICAL DISINFECTANTS (1984) (257)
ISOLATION OF NEW LYMPHOTROPIC RETROVIRUS FROM TWO SIBLINGS WITH HAEMOPHILIA B, ONE WITH AIDS (1984) (245)
The multitude and diversity of environmental carcinogens. (2007) (241)
DETECTION OF IgG ANTIBODIES TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN PATIENTS WITH AIDS OR LYMPHADENOPATHY SYNDROME (1984) (228)
Replicative form of Encephalomyocarditis Virus Ribonucleic Acid (1963) (196)
Early viral replication in the brain of SIV-infected rhesus monkeys. (1991) (191)
Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. (1994) (181)
Human immunodeficiency virus type 1–infected monocytic cells can destroy human neural cells after cell‐to‐cell adhesion (1992) (169)
HIV/HTLV gene nomenclature (1988) (162)
Human microglial cells: Characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV‐1 infection (1991) (157)
DNA waves and water (2010) (155)
The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. (1988) (152)
ANTIMONIOTUNGSTATE (HPA 23) TREATMENT OF THREE PATIENTS WITH AIDS AND ONE WITH PRODROME (1985) (150)
INFECTION OF CHIMPANZEES BY HUMAN T-LYMPHOTROPIC RETROVIRUSES IN BRAIN AND OTHER TISSUES FROM AIDS PATIENTS (1985) (148)
Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). (1984) (148)
Kaposi's sarcoma and new herpesvirus (1995) (146)
Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. (1985) (144)
Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins (1989) (140)
Molecular cloning of lymphadenopathy-associated virus (1984) (137)
AIDS in 1988. (1988) (137)
Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. (1993) (132)
Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A. (1979) (128)
The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. (1987) (127)
ACUTE NEUROPATHY COINCIDENT WITH SEROCONVERSION FOR ANTI-LAV/HTLV-III (1986) (126)
Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. (1984) (124)
Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. (1984) (123)
Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. (1984) (122)
AIDS-associated mycoplasmas. (1994) (118)
INFECTION OF CHIMPANZEES WITH LYMPHADENOPATHY-ASSOCIATED VIRUS (1984) (116)
VPX mutants of HIV‐2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. (1989) (111)
Comparison of Early and Late Feline Immunodeficiency Virus Encephalopathies (1992) (110)
A History of HIV Discovery (2002) (108)
ABSENCE OF ANTIBODIES TO AIDS VIRUS IN HAEMOPHILIACS TREATED WITH HEAT-TREATED FACTOR VIII CONCENTRATE (1985) (103)
Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells. (1990) (100)
A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. (1990) (98)
Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion. (1993) (96)
Human herpesvirus-6 strain groups: a nomenclature (1993) (95)
Improved antigenicity of the HIV env protein by cleavage site removal. (1988) (94)
Programmed Cell Death as a Mechanism of CD4 and CD8 T Cell Deletion in AIDS: Molecular Control and Effect of Highly Active Anti‐retroviral Therapy (1999) (93)
Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis (1989) (93)
Transduction of DNA information through water and electromagnetic waves (2014) (93)
AIDS virus env Protein Expressed from a Recombinant Vaccinia Virus (1986) (92)
Prospects for the Future (2002) (90)
Inactivation, by UV-, x-, and gamma-radiations, of the infecting and transforming capacities of polyoma virus. (1967) (89)
CONCOMITANT INFECTION BY HUMAN HERPESVIRUS 6, HTLV-I, AND HIV-2 (1988) (89)
ISOLATION OF HUMAN T-LYMPHOTROPIC RETROVIRUS (LAV) FROM ZAIRIAN MARRIED COUPLE, ONE WITH AIDS, ONE WITH PRODROMES (1984) (89)
Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression (1994) (88)
Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells. (1994) (87)
A rapid and simple colorimetric test for the study of anti-HIV agents. (1988) (87)
The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. (1993) (86)
Spermatozoa as potential carriers of HIV. (1993) (84)
Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases (1997) (81)
Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines (1992) (80)
The chronology of AIDS research (1987) (80)
Isotypic restriction of the antibody response to human immunodeficiency virus. (1988) (79)
Autoantibodies typical of non‐organ‐specific autoimmune diseases in HIV‐seropositive patients (1992) (78)
Molecular Evidence for Nosocomial Transmission of Human Immunodeficiency Virus from a Surgeon to One of His Patients (1998) (78)
In vitro sensitivity of human herpesvirus-6 to antiviral drugs. (1989) (77)
A new type of retrovirus isolated from patients presenting with lymphadenopathy and acquired immune deficiency syndrome: Structural and antigenic relatedness with equine infectious anaemia virus (1984) (77)
Influence of microbial infections on the progression of HIV disease. (1997) (75)
Lymphadenopathy-associated virus: from molecular biology to pathogenicity. (1985) (74)
HIV-2 antisera cross-neutralize HIV-1. (1988) (73)
Longitudinal study of 18 children with perinatal LAV/HTLV III infection: attempt at prognostic evaluation. (1986) (72)
Effect of interferon-alpha 1 from E. coli on some cell functions. (1980) (71)
Screening for lymphadenopathy/AIDS virus in bone marrow-transplant recipients. (1986) (68)
Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication (1988) (67)
Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing (1989) (67)
Antigenic and genetic differentiation of the two putative types of human herpes virus 6. (1993) (66)
Applications and bioefficacy of the functional food supplement fermented papaya preparation. (2010) (65)
New concepts in AIDS pathogenesis. (1993) (65)
Early SIV encephalopathy. (1991) (63)
Selective depletion of low-density CD8+, CD16+ lymphocytes during HIV infection. (1988) (60)
25 years after HIV discovery: prospects for cure and vaccine. (2010) (58)
Isolation of a new retrovirus in a patient at risk for acquired immunodeficiency syndrome. (1983) (58)
Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding (1989) (58)
A possible subunit structure of Rous sarcoma virus RNA. (1969) (57)
FATAL ACUTE HIV INFECTION WITH APLASTIC ANAEMIA, TRANSMITTED BY LIVER GRAFT (1988) (57)
Mycoplasmas as cofactors in infection due to the human immunodeficiency virus. (1993) (57)
Inhibition of RNA-dependent DNA polymerases of AIDS and SAIDS retroviruses by HPA-23 (ammonium-21-tungsto-9-antimoniate) (1985) (56)
Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160 (1992) (55)
Immunology: Approaches to AIDS therapy (1986) (55)
Lack of systematic correlation between the interferon mediated antiviral state and the levels of 2-5A synthetase and protein kinase in three different types of murine cells. (1981) (55)
Human immunodeficiency virus infection and AIDS in a person with negative serology. (1997) (54)
Severe encephalitis resulting from coinfections with HIV and JC virus (1990) (53)
Role of Mycoplasma penetransEndonuclease P40 as a Potential Pathogenic Determinant (1999) (52)
Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus. (1995) (52)
Immunosuppressive properties of synthetic peptides derived from CD4 and HLA-DR antigens (1988) (50)
Viral load and neuropathology in the SIV model. (1999) (50)
Electromagnetic detection of HIV DNA in the blood of AIDS patients treated by antiretroviral therapy (2009) (49)
Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers (1990) (49)
TRANSMISSIBILITY OF HUMAN IMMUNODEFICIENCY VIRUS IN HAEMOPHILIC AND NON-HAEMOPHILIC CHILDREN LIVING IN A PRIVATE SCHOOL IN FRANCE (1986) (48)
Historical essay. A history of HIV discovery. (2002) (48)
Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV‐1 by deletion of the env amino‐terminal signal sequence (1990) (47)
Homology of double stranded RNA from rat liver cells with cellular genome. (1971) (47)
HIGH PREVALENCE OF LYMPHADENOPATHY VIRUS (LAV) IN EUROPEAN HAEMOPHILIACS (1984) (46)
Genetic differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque (1992) (45)
Primary cytotoxicity against the envelope glycoprotein of human immunodeficiency virus-1: evidence for antibody-dependent cellular cytotoxicity in vivo. (1990) (45)
Spiralin, a mycoplasmal membrane lipoprotein, induces T-cell-independent B-cell blastogenesis and secretion of proinflammatory cytokines (1997) (45)
[Demonstration of an engagement process towards cell death by apoptosis in lymphocytes of HIV infected patients]. (1991) (45)
Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein. (1989) (45)
A study of seroprevalence of HIV-1 and HIV-2 in six provinces of People's Republic of Angola: clues to the spread of HIV infection. (1990) (44)
Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19 (2020) (44)
Lymphadenopathy associated virus and its etiological role in AIDS. (1984) (44)
The Relationship Between the Interferon α Response and Viral Burden in Primary SIV Infection (1996) (44)
Selective anergy of V beta 8+ T cells in human immunodeficiency virus- infected individuals (1994) (44)
Relationship of AIDS to other retroviruses (1985) (43)
Interferon messenger RNA: translation in heterologous cells. (1972) (43)
Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients. (1989) (42)
CELL TRANSFORMATION BY DIFFERENT FORMS OF POLYOMA VIRUS DNA. (1964) (41)
Development of PCR-based assays for the detection of two human mollicute species, Mycoplasma penetrans and M. hominis. (1994) (41)
Interferon-mediated antiviral state in human MRC5 cells in the absence of detectable levels of 2-5A synthetase and protein kinase. (1981) (41)
The relationship between the interferon alpha response and viral burden in primary SIV infection. (1996) (40)
Human immunodeficiency viruses [letter] (1986) (39)
Efficiency of poly(A).poly(U) as an adjuvant. (1988) (38)
Purification and characterization of Mycoplasma penetrans Ca2+/Mg2+-dependent endonuclease (1997) (38)
HIV-2 EHO isolate has a divergent envelope gene and induces single cell killing by apoptosis. (1994) (37)
Encephalomyocarditis Virus and its Ribonucleic Acid: Sedimentation Characteristics: Sedimentation Properties of Infective Ribonucleic Acid extracted from Encephalomyocarditis Virus (1963) (35)
Cell surface expression of several species of human immunodeficiency virus type 1 major core protein (1989) (35)
Detection of natural autoantibodies in the serum of anti-HIV-positive individuals. (1987) (34)
Biosynthesis of mouse interferon by translation of its messenger RNA in a cell-free system. (1975) (34)
Organization of Ureaplasma urealyticum urease gene cluster and expression in a suppressor strain of Escherichia coli (1996) (34)
Water Bridging Dynamics of Polymerase Chain Reaction in the Gauge Theory Paradigm of Quantum Fields (2017) (34)
In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals (1995) (33)
Clinical and Biological Evolution of HIV‐1 Seroconverters in Abidjan, Côte d’Ivoire, 1997‐2000 (2002) (33)
Immune correlates of protection from HIV infection and AIDS. (1997) (33)
Oxidative protein damage and degradation in lymphocytes from patients infected with human immunodeficiency virus. (1997) (32)
Target cells during early SIV encephalopathy. (1993) (32)
Development of a selective and sensitive polymerase chain reaction assay for the detection of Mycoplasma pirum. (1993) (32)
A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. (1986) (32)
TRANSMISSION EXPERIMENTS WITH HUMAN T-LYMPHOTROPIC RETROVIRUSES AND HUMAN AIDS TISSUE (1984) (31)
Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome. (1985) (31)
Early events in lymph nodes during infection with SIV and FIV. (1994) (30)
Search for the presence of six Mycoplasma species in peripheral blood mononuclear cells of subjects seropositive and seronegative for human immunodeficiency virus (1996) (30)
Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans. (1992) (30)
Cell-mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinant viruses. (1989) (30)
Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia. (1980) (30)
Production of a non-functional nef protein in human immunodeficiency virus type 1-infected CEM cells. (1990) (30)
Lymphadenopathy syndrome in two thalassemic patients after LAV contamination by blood transfusion. (1985) (30)
HIV-1 antibody serum negativity with urine positivity (1993) (30)
Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS. (1985) (29)
SUSCEPTIBILITY OF HUMAN HERPESVIRUS 6 TO ACYCLOVIR AND GANCICLOVIR (1989) (29)
Lymphadenopathy-associated-virus infection and acquired immunodeficiency syndrome. (1986) (29)
Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons (1977) (29)
Virus load and neuropathology in the FIV model. (1996) (29)
Molecular characterization of the P1-like adhesin gene from Mycoplasma pirum (1994) (28)
A longitudinal study of seroreactivity against Mycoplasma penetrans in HIV-infected homosexual men: association with disease progression. (1998) (28)
Phase variations of the Mycoplasma penetrans main surface lipoprotein increase antigenic diversity. (1999) (28)
Growth in Agarose of Human Cells Infected With Cytomegalovirus (1970) (28)
Characterization of a major Mycoplasma penetrans lipoprotein and of its gene. (1995) (26)
HIV-1 core proteins expressed from recombinant vaccinia viruses. (1989) (26)
Enhancement of interferon-mediated protein kinase in mouse and human plasma in response to treatment with polyadenylic-polyuridylic acid (poly A:poly U). (1982) (25)
Detection of HHV-6 by the polymerase chain reaction. (1991) (25)
A molecular mechanism of inhibition of HIV-1 binding to CD4+ cells by monoclonal antibodies to gp110. (1988) (25)
Identification of Mycoplasma pirum genes involved in the salvage pathways for nucleosides (1993) (25)
DEFICIENT LAV1 NEUTRALISING CAPACITY OF SERA FROM PATIENTS WITH AIDS OR RELATED SYNDROMES (1985) (25)
ANTICELLULAR AND ANTIVIRAL EFFECTS OF PPPA(2′P5′A)N (1980) (25)
Sequences related to mouse mammary tumor virus genome in tumor cells and lymphocytes from patients with breast cancer. (1984) (24)
Different proliferative response of human and chimpanzee lymphocytes after contact with human immunodeficiency virus type 1 gp120 (1994) (24)
Efficacy and safety of Buxus sempervirens L. preparations (SPV(30)) in HIV-infected asymptomatic patients: a multicentre, randomized, double-blind, placebo-controlled trial. (1998) (24)
Export and one-step purification from Escherichia coli of a MalE-CD4 hybrid protein that neutralizes HIV in vitro. (1990) (23)
Isolation of atypical HIV-1-related retrovirus from AIDS patient (1992) (23)
Lymphadenopathy associated virus: its role in the pathogenesis of AIDS and related diseases. (1986) (23)
Protein kinase (pp67-IFN) in plasma and tissues of mice with high levels of circulating interferon (1981) (23)
18-S and 30-S fractions from the RNA of Krebs-2 ascites cells with differing base composition (1964) (23)
Identification of two glycosylated components of Mycoplasma penetrans: a surface-exposed capsular polysaccharide and a glycolipid fraction. (1998) (22)
[Infectivity inhibition of HIV prototype strains by antibodies directed against a peptide sequence of mycoplasma]. (1990) (21)
Induction of interferon by streptococcus pyogenes extracellular products. (1982) (20)
Amino acid changes in the fourth conserved region of human immunodeficiency virus type 2 strain HIV-2ROD envelope glycoprotein modulate fusion (1993) (20)
Lorentz force in water: evidence that hydronium cyclotron resonance enhances polymorphism (2015) (20)
Selective loss of the CD4+/CD26+ T-cell subset during HIV infection. (1996) (20)
Oxidative stress in critical care medicine (2010) (19)
Effects of calcium ions on proteolytic processing of HIV‐1 gp160 precursor and on cell fusion (1994) (19)
Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infection. (1990) (19)
Early stages of feline immunodeficiency virus infection in lymph nodes and spleen. (1994) (18)
Protein kinase in human plasma analogous to that present in control and interferon-treated HeLa cells. (1981) (18)
WHO Working Group on Characterization of HIV-Related Retroviruses: criteria for characterization and proposal for a nomenclature system. (1987) (18)
Enhancement of retrovirus production by anti-interferon serum. (1979) (18)
Two forms of mouse interferon messenger RNA. (1974) (18)
Immunogenicity and antigenicity of conserved peptides from the envelope of HIV-1 expressed at the surface of recombinant bacteria. (1990) (17)
Phylogenetic analysis of Mycoplasma penetrans, isolated from HIV-infected patients. (1993) (17)
Infection of baboons with human immunodeficiency virus-2 (HIV-2) (1987) (16)
Specificity of antipeptide antibodies produced against V2 and V3 regions of the external envelope of human immunodeficiency virus type 2. (1994) (16)
An epithelioid variant of the BHK21 hamster fibroblast line and its transformation by polyoma virus. (1966) (16)
ROUTES OF HIV-2 TRANSMISSION IN WESTERN EUROPE (1987) (16)
Characterization of monoclonal antibody specific for human alpha interferon. (1982) (16)
Use of an anti-human leukocyte interferon monoclonal antibody for the purification and radioimmunoassay of human alpha interferon (1982) (16)
Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160 (1993) (16)
A structural change of the plasma membrane induced by oncogenic viruses: quantitative studies with the freeze-fracture technique. (1975) (15)
Validation of a single-platform, volumetric, flow cytometry for CD4 T cell count monitoring in therapeutic mobile unit (2012) (15)
Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. (1986) (15)
Production and characterization of human monoclonal antibodies against core protein p25 and transmembrane glycoprotein gp41 of HIV-1. (1990) (15)
Studies on the ultrastructure of concanavalin a receptor sites at the surface of normal cells and cells transformed by oncogenic viruses (1973) (15)
Retroviruses and AIDS (1985) (15)
Is a dominant superantigen involved in AIDS pathogenesis? (1993) (14)
Approaches to AIDS therapy. (1986) (14)
Large fragments of nef-protein and gp110 envelope glycoprotein from HIV-1. Synthesis, CD analysis and immunoreactivity. (2009) (14)
Association of tyrosine protein kinase activity with mitochondria in human fibroblasts (1986) (14)
Phase Variations of the Mycoplasma penetrans Main Surface Lipoprotein Increase Antigenic Diversity (1999) (14)
Specificity and neutralizing capacity of three monoclonal antibodies produced against the envelope glycoprotein of simian immunodeficiency virus isolate 251. (1995) (13)
Kinetics of primary SIV infection in lymph nodes (1994) (13)
Co-cultivation of human herpesvirus 6 and HIV1 from blood lymphocytes. (1989) (13)
Origin and evolution of HIVs and their role in AIDS pathogenesis. (1988) (12)
Interferon-gamma expression in macaque lymph nodes during primary infection with simian immunodeficiency virus. (1996) (12)
Increased plasma thiobarbituric acid-reactive substances (TBARS) before opportunistic infection symptoms in HIV infected individuals. (1996) (12)
Characterization of a monoclonal antibody specific for the HIV-1 precursor glycoprotein. (1988) (12)
High production of the acquired immunodeficiency syndrome virus (lymphadenopathy-associated virus) by human T lymphocytes stimulated by streptococcal mitogenic toxins (1986) (12)
Genetic Variability in Human Immunodeficiency Viruses (1987) (12)
Atypical HIV serological profile of novel HIV-1 variant distinct from subtype O (1995) (12)
Glucose-regulated membrane properties of untransformed and virus-transformed BHK21 cells. (1979) (11)
COVID-19, SARS AND BATS CORONAVIRUSES GENOMES PECULIAR HOMOLOGOUS RNA SEQUENCES (2020) (11)
Identification and characterization of tyrosine kinase activity associated with mitochondrial outer membrane in sarcoma 180 cells (1988) (11)
Inhibition of HIV replication: a powerful antiviral strategy by IFN-beta gene delivery in CD4+ cells. (2007) (11)
Antiviral action of polyadenylic-polyuridylic acid against HIV in cell cultures. (1992) (11)
Low susceptibility of resident microglia to simian immunodeficiency virus replication during the early stages of infection (1995) (11)
Lymphadenopathy/AIDS virus: genetic organization and relationship to animal lentiviruses. (1986) (11)
Clinical and virological aspects of HIV2 infection in rhesus monkeys. (1992) (11)
N-linked oligosaccharides of simian immunodeficiency virus envelope glycoproteins are dispensable for the interaction with the CD4 receptor. (1993) (10)
[Functional inhibition by cyclosporin A of the lymphocyte receptor for the AIDS virus (HIV)]. (1986) (10)
Apoptosis as a Mechanism of Cell Death in Peripheral Lymphocytes from HIV-1-Infected Individuals (1992) (9)
Anti HIV-2 serological screening in Portuguese populations native from or having had close contact with Africa. (1987) (9)
Prevention of early cell death in peripheral blood lymphocytes of HIV infected individuals by an anti-oxidant: N-Acetyl-Cysteine (1994) (9)
Newsmaker interview: Luc Montagnier. French Nobelist escapes 'intellectual terror' to pursue radical ideas in China. Interview by Martin Enserink. (2010) (9)
Detection of human immunodeficiency virus type 2 in brain tissue. (1992) (9)
Enhancement of mitochondrial tyrosine kinase activity following viral transformation. (1988) (9)
Multiple cytotoxic effector cells are induced by infection with the human immunodeficiency virus. (1989) (9)
Factors and Mechanisms of AIDS Pathogenesis1 (1992) (9)
Nef vaccination against HIV disease (1995) (9)
LYMPHADENOPATHY ASSOCIATED VIRUS IN AIDS, LYMPHADENOPATHY ASSOCIATED SYNDROME, AND CLASSIC KAPOSI PATIENTS IN GREECE (1984) (8)
LACK OF EVIDENCE FOR HUMAN OR SIMIAN T-LYMPHOTROPIC VIRUSES TYPE III INFECTION IN PYGMIES (1986) (8)
Un intermĕdiaire ADN infectieux et transformant du virus du sarcome de Rous dans le cellules de poule transformĕes par ce virus. (1972) (8)
Virus: The Co-discoverer of HIV Tracks Its Rampage and Charts the Future (1999) (8)
Antibodies to lav in various population groups of the Central African Republic (1985) (8)
COVID-19, SARS and Bats Coronaviruses Genomes Unexpected Exogeneous RNA Sequences (2020) (8)
Transmission of human T-lymphotropic retrovirus infection to chimpanzees using brain and other tissues from AIDS patients (1985) (8)
Characterization of a nuclear retention sequence within the 3' region of the HIV-2 envelope gene. (1993) (8)
New concepts in the mechanisms of CD4+ lymphocyte depletion in AIDS, and the influence of opportunistic infections. (1992) (7)
Accessibility of the highly conserved amino- and carboxy-terminal regions from HIV-1 external envelope glycoproteins. (1989) (7)
Cyclosporine A treatment for human immunodeficiency virus-infected transplant recipients. (1987) (7)
Nuclear and mitochondrial origin of rat liver double-stranded RNA. (1975) (7)
Effects ofMutations inHyperconserved Regions ofthe Extracellular Glycoprotein ofHumanImmunodeficiency Virus Type1on Receptor Binding (1989) (7)
Organization of Ureaplasma urealyticum urease gene cluster and expression in a suppressor strain of Escherichia coli (1996) (6)
A sensitive dot immunobinding assay for the detection of antibodies specific for HIV (1987) (6)
Bromodeoxyuridine‐induced reversion of transformed characteristics in BHK21 cells: Changes at the plasma membrane level (1979) (6)
Historical accuracy of HIV isolation (2003) (6)
Modulation of cell growth and host protein synthesis during HIV infection in vitro. (1992) (6)
IMMUNE STATUS OF AIDS PATIENTS IN FRANCE: RELATIONSHIP WITH LYMPHADENOPATHY ASSOCIATED VIRUS TROPISM a (1984) (6)
Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor. (1994) (6)
Characterization of humoral immune responses induced by immunization with plasmid DNA expressing HIV-1 Nef accessory protein. (1998) (6)
Lymphadenopathy associated virus and AIDS (1985) (6)
Factors Controlling the Multiplication of Untransformed and Transformed BHK2I Cells Under Various Environmental Conditions (2008) (6)
The human immune deficiency virus (HIV): An update (1987) (6)
Protease activation during HIV infection in a CD4-positive cell line. (1990) (6)
Inhibition of HIV type 1 reverse transcriptase assay by nucleases produced by contaminating mycoplasmas. (1994) (6)
HIV Replication in the Central Nervous System of AIDS Patients (1990) (5)
IRRADIATION OF ONCOGENIC VIRUSES: DISSOCIATION OF VIRAL FUNCTIONS. (1967) (5)
A Plea for Justice for Jailed Medical Workers (2006) (5)
Interferon-mediated protein kinase in mouse cells treated with iododeoxyuridine (IdUrd) and induced to express endogenous retroviruses. (1981) (5)
Prevalence of Antibodies to Lymphadenophahy‐AIDS Virus in French Haemophiliacs (1985) (5)
[Contribution of animal models in the understanding of AIDS encephalopathy]. (1997) (5)
Inhibition fonctionnelle par la ciclosporine A du récepteur lymphocytaire du virus du sida (HIV) (1986) (5)
Infectious dna recovered from avian tumor‐virus‐producing cells (1975) (5)
ACTH/beta-endorphins and ACTH/cortisol ratios as early biological markers in HIV infection. (1990) (5)
HUMAN IMMUNODEFICIENCY VIRUSES (RETROVIRIDAE) | General Features (1999) (5)
Purification of human leukocyte interferon to homogeneity with the use of a monoclonal antibody: Detailed technique and parameters (1983) (5)
Specificity of anti-Nef antibodies produced in mice immunized with DNA encoding the HIV-1 nef gene product. (1999) (5)
25 years after HIV discovery: prospects for cure and vaccine (Nobel lecture). (2009) (5)
Increase of a high molecular weight protein in plasma membranes of BHK21 cells transformed by hamster sarcoma virus. (1977) (4)
The possible role of a new lymphotropic retrovirus (LAV) in the pathogeny of AIDS and AIDS-related diseases. (1985) (4)
Disc-agarose assay of interferon and cytostatic drugs on malignant cells (1980) (4)
A new type of retrovirus isolated from patients presenting with lymphadenopathy and aquired immunodeficiency syndrome:structural and antigenic relatedness with EIQ virus (1984) (4)
[Cellular surface changes induced by oncogenic viruses and their role in malignant transformation]. (1970) (4)
Longitudinal assessment of persistent generalized lymphadenopathy (PGL) in homosexual men. (1985) (4)
Induction of EBV DNA demethylation and of EBV-specific transcription in Daudi cells treated with TPA and n-butyrate. (1984) (4)
Biological and biochemical criteria for the characterization of the transformed stage of BHK21 cells. (1979) (4)
Functional mapping of the rev-responsive element of human immunodeficiency virus type 2 (HIV-2): influence of HIV-2 envelope-encoding sequences on HIV-1 gp120 expression in the presence or absence of Rev. (1992) (4)
RIBAVIRIN IN HTLV-III:LAV INFECTION OF INFANTS (1986) (4)
Techniques in HIV research Edited by A. Aldovini and B. D. Walker. New York: Stockton Press. (1990). 285 pp. $49.95 (1991) (4)
Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles. (2002) (3)
SIX FRACTAL CODES OF LIFE FROM BIOATOMS ATOMIC MASS TO CHROMOSOMES NUMERICAL STANDING WAVES: THREE BREAKTHOUGHS IN ASTROBIOLOGY, CANCERS AND ARTIFICIAL INTELLIGENCE (2021) (3)
Increased nuclease activity in cells treated with pppA 2 ' p 5 ' A 2 ' p 5 ' A ( protein synthesis / interferon action / reticulocyte lysates / calcium phosphate coprecipitation (3)
Specificity of anti-peptide antibodies elicited against synthetic peptides mimicking conserved regions of HIV1 envelope glycoprotein. (1991) (3)
High recurrence of rearrangements involving chromosome 14 in an ataxia telangiectasia lymphoblastoid cell line and in its mutagen-treated derivatives (1991) (3)
Membrane changes in virus transformed cells. (1976) (3)
Roundtable: can experience with veterinary retroviral vaccines be applied to the human situation? (1996) (3)
AIDS research at EC level. (1995) (3)
Toward functional eradication of HIV infection (2007) (3)
Infectious DNA intermediate of an oncogenic RNA virus. (1973) (3)
[SELECTIVE DEVELOPMENT IN AGAR OF HAMSTER CELLS TRANSFORMED BY THE POLYOMA VIRUS]. (1964) (3)
[The virus of human immunodeficiency]. (1987) (3)
High prevalence of antibodies to Mycoplasma penetrans in human immunodeficiency virus-seronegative and -seropositive populations in Brazzaville, Congo (1997) (3)
[The selective growth in agar of cells transformed by a cancerogenic virus]. (1966) (3)
Uptake of amino acids and thymidine during the first cell cycle of synchronized hamster cells (1976) (3)
AIDS vaccines: concepts and first trials. (1989) (3)
Environmental pathogenesis of human retroviruses. (1996) (3)
Replication and action of oncogenic viruses. (1970) (2)
A new human retrovirus associated with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. (1985) (2)
Inhibition of in vitro HIV infection by trinitrophenyl-protein conjugates. (1995) (2)
[Isolation of a cellular hybrid secreting an antibody specific for human leukocyte interferon]. (1980) (2)
Addendum: Montagnier, L.; Aïssa, J.; Capolupo, A.; Craddock, T.J.A.; Kurian, P.; Lavallee, C.; Polcari, A.; Romano, P.; Tedeschi, A.; Vitiello, G. Water Bridging Dynamics of Polymerase Chain Reaction in the Gauge Theory Paradigm of Quantum Fields. Water 2017, 9, 339 (2017) (2)
[HIV-2 virus infection with long incubation period]. (1987) (2)
3.1 Structure and function of HIV (1996) (2)
Managing HIV. Part 3: Mechanisms of disease. 3.1 Structure and function of HIV. (1996) (2)
[Infection by the LAV virus and the acquired immunodeficiency syndrome]. (1985) (2)
[Retroviruses and acquired immunodeficiency syndrome (AIDS)]. (1984) (2)
Analysis and Immunological Properties of Lymphadenopathy Associated Virus (LAV) Structural Proteins (1985) (2)
25 Years After HIV Discovery: Prospects for Cure and Vaccine (Nobel Lecture) (2009) (2)
[Cytotoxic and antitumor activity of a new series of heterocyclic compounds: dipyrido (4,3-b) (3,4-f) indoles]. (1977) (1)
[Titration of the infectious ribonucleic acid of the mouse encephalomyocarditis virus on ascites Krebs II cells in vitro]. (1962) (1)
A new purine analogue with antimitotic activity. (1974) (1)
Emergence of a New Creutzfeldt-Jakob Disease: 26 Cases of the Human Version of Mad-Cow Disease, Days After a COVID-19 Injection (2023) (1)
AIDS priority (1984) (1)
HIV's leading men. (2011) (1)
T-Cell Derived Suppressor Factors in the Regulation of Humoral Immunity (1988) (1)
Validation of a single-platform, volumetric, flow cytometry for CD4 T cell count monitoring in therapeutic mobile unit (2012) (1)
[The immunodeficiency retrovirus in man and primates]. (1989) (1)
A Novel Human Lymphotropic Retrovirus (LAV): New Data on Its Biology and Role in AIDS (1985) (1)
[Cytostatic action of 2-nitronaph-thofurans on L1210 murine leukemia cells in semi-solid médium (author's transl)]. (1981) (1)
Molecular analysis of receptor binding and infectivity of the human immunodeficiency virus. (1989) (1)
Purification and Characterization of Mycoplasma penetrans Ca 2 1 / Mg 2 1-Dependent Endonuclease (1997) (1)
Studies of a large transformation-increased membrane protein in the BHK21 cell system. (1979) (1)
European Network for Treatment of AIDS (ENTA) (1995) (1)
Identification of an Adhesin‐Like Gene of Mycoplasma pirum Isolated from AIDS Patients (1994) (1)
Intracellular location of the two small RNA coded by Epstein-Barr virus genome and their variations according to viral expression (1984) (1)
Molecular Characterization ofthePl-Like Adhesin Genefrom Mycoplasma pirum (1994) (1)
Purification of the major species of human leucocyte interferon with the help of a monoclonal antibody. (1984) (1)
[Role of liposomes in the presentation of HIV envelope glycoprotein and the immune response in mice]. (1989) (1)
Candidate vaccines for HIV (1989) (1)
Dynamics and heterogeneity of the epidemic. (2007) (1)
Subject Index, Vol. 22, 1984 (1984) (1)
Purification and Characterization ofMycoplasma penetrans Ca 21 /Mg 21 -Dependent Endonuclease (1997) (1)
An acidic cell compartment is probably involved in mediating the induction of 2–5A synthetase by human α interferon (1985) (1)
Protein synthesis and changes in DNA-sarkosyl complexes during the S-phase of synchronised BHK21 cells. (1973) (1)
Diphenylhydantoin (DPH) blocks HIV-receptor on T-lymphocyte surface (1986) (1)
Enhanced replication of herpes simplex virus type 1 in BHK-21 cells transformed by hamster sarcoma virus. (1980) (1)
New HIV-Related Viruses (1989) (0)
Research letterCharacterization of a major Mycoplasma penetrans lipoprotein and of its gene (1995) (0)
[Ultrastructural changes of the surface of BHK 21-13 transformed cells, depending on adenine nucleotides]. (1970) (0)
Synthesis of the proteins or polypeptides encoded by a nucleotide sequence of HIV-1, HIV-2 or SIV. (1990) (0)
Lymphadenopathy-Associated Virus: From Molecular Biology to Pathogenicity (1986) (0)
[An intermediary, infectious and transforming DNA of the Rous sarcoma virus in chicken cells transformed by this virus]. (1972) (0)
Cancer Biology Reviews, vol. 3, J.J. Marchalonis, M.G. Hanna. Marcel Dekker, New-York, Chichester (1982), 221 p. (1983) (0)
Fetal tissue implants: therapy for Parkinson's disease?. Interview by Kevin Tanzillo. (1992) (0)
Production of envelop antigen of lymphadenopathy and acquired immune deficiency syndrome virus and use of the antigen for preparing immunogen composition or detecting antibody against the virus (1994) (0)
Contents, Vol. 22, 1984 (1984) (0)
Nucleic acid fragments and the HHV6 / SIE virus genome derived diagnostics and methods for diagnosis of HHV-6 infection (1990) (0)
Five cases of pnuemocystis carinii Pneumonia (PCP), a rare opportunistic infection in immunocompromised persons, were reported in previously healthy and young gay men from Los Angeles in 1981 (2012) (0)
Nucleotide sequences of HIV-1, HIV-2 and SIV retrovirus genomes, their use for amplification of pol sequences of these retroviruses and for in vitro diagnostic of infections caused these viruses (1990) (0)
Immunodeficiency Editorial overview (1990) (0)
RoleofMycoplasma Infection intheCytopathic Effect Induced by HumanImmunodeficiency VirusType1inInfected CellLines (1992) (0)
Protein or polypeptide encoded by a Nukleinsaüresequenz of HIV-1, HIV-2 or SIV. (1990) (0)
Envelope antigens from the human immunodeficiency virus and uses thereof. (1985) (0)
[Synchronization of BHK 21 cells through partial deprivation of L-asparagine]. (1974) (0)
LYMPHADENOPATHY (PGL) IN HOMOSEXUAL MEN (1985) (0)
[Presence of autocomplementary RNA with viral specificity in cells infected with herpes virus]. (1975) (0)
Purified and isolated retrovirus of hiv (1993) (0)
Expression vector containing dna insert fragment hybridizable with genomic rna of llymphadenophaty-associated vitrus and its expression product (1996) (0)
nucleotide sequences derived from the genome of type retroviruses HIV-1, HIV-2 and SIV, and applications especially for amplification of the genomes of retroviruses and for the in vitro diagnosis of infections caused by these viruses. (1990) (0)
Conference on World Development (2004) (0)
LAV antigens and peptides (1985) (0)
AIDS diagnostic test based on the implementation of a diversity of evidence isotype response, vaccines and serotherapies (1987) (0)
Heterogeneity oftheSensitivity ofVesicular Stomatitis Virus toInterferons (1977) (0)
The use of dinitro-trinitrophenyl (1989) (0)
Diagnostic test, vaccine and serum therapy for aids based on detection of versatility of isotype response (1988) (0)
[Presence of a double chain ribonucleic acid in animal cells]. (1968) (0)
Type retroviruses HIV-2 capable of causing AIDS, antigenic and nucleic constituents. (1987) (0)
Autobiography of Luc Montagnier (2010) (0)
Le SIDA et son origine virale (1985) (0)
Does HIV NEF Protein Belong to the G-Protein Family? (1989) (0)
viral vector and recombinant DNA coding for a glycoprotein of the virus causative agent of AIDS, cell culture infected by this vector, process for the preparation of the glycoprotein, glycoprotein obtained, vaccine and antibody obtained (1986) (0)
For a Coherent and Global Strategy of AIDS Research (1995) (0)
Nucleotides sequences of retroviral antigenic HIV-I group (or subgroup) o (1995) (0)
Compositions Pharmaceutical drug for the treatment of the syndrome of the acquired immunodeficiency syndrome (AIDS) and related (1985) (0)
Characterization of the Cytotoxic Immune Responses to HIV-11 (1992) (0)
Specificity ofAntibodies Produced againstNative or Desialylated HumanImmunodeficiency VirusType1Recombinant gpl60 (1993) (0)
Viral vector coding for a glycoprotein of the virus responsible for AIDS vaccine, comprising the virus vector or the glycoprotein, as well as antibody to the glycoprotein (1987) (0)
Indole derivatives, processes for their manufacture and to compositions comprising drug (1978) (0)
Human Activities Are Causing Selection of Pathogenic Agents (1998) (0)
Low polypeptide encoded by DNA sequence (1993) (0)
HIV MAN-MANIPULATED CORONAVIRUS GENOME EVOLUTION TRENDS (2020) (0)
Aids : facts & hopes (1996) (0)
Mitogenes streptococciques specifiques des lymphocytes t4, leur application a la stimulation de la production de virus lav (1986) (0)
[Double transformation of hamster cells by Rous and polyoma viruses]. (1969) (0)
F antigenic by the human immunodeficiency virus and uses thereof. (1985) (0)
Molecular analysis of receptor binding and viral tropism. (1991) (0)
Antigen and virus, method of preparation of the antigen, using antigens in the preparation of immunogenic compositions or for the diagnosis of antibodies against the virus (1986) (0)
Fragments of nucleic acids and diagnostic reagents derived from the genome of HHV6 / sie infections and diagnostic process for HHV6 (1989) (0)
Rna corresponding to lymphadenopathy-associated virus(lav) genome, obtainable from reverse transcription of cloned dna hybridizable with genomic rna of lav (1994) (0)
Nucleotide sequences derived from the genome of the retrovirus of the type HIV-1, HIV-2 and SIV, and their use, preferably for OPF (1990) (0)
Application of dinitro-trinitrophenyl and its derivatives or anti-nitrophenyl antibodies modifying the interaction between the sensitive cells of a host and a pathogenic agent (1987) (0)
Antigen to virus for lymphadenosis and/or acquired immune deficiency syndrome (aids) (1996) (0)
Nucleotide sequences from the genome of retroviruses of hiv-1 type, hiv-2 and SIV, and applications including amplification of genomes of these retroviruses and for in-vitro diagnosis of infections with these viruses. (1989) (0)
Identification ofMycoplasma pirumGenesInvolved inthe Salvage Pathways forNucleosides (1993) (0)
O T ] 2 3 D ec 2 01 0 DNA waves and water (2010) (0)
Method microorganism detection in a sample (2006) (0)
[Specific phosphorylation of a calf serum protein by a kinase from the cell surface]. (1979) (0)
Variants of lav-virus, the dns and protein components and their use, for diagnostic purposes in particular and the production of immunogenic compositions. (1987) (0)
Antigen, process for the preparation of the antigen, method of diagnosing and immunogenic compositions (1986) (0)
Nucleotide sequences of the genome of type retroviruses HIV-1, HIV-2 and SIV, their uses for the amplification of these genomes and in vitro diagnosis of these viral infections (1990) (0)
Erratum to: Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019 (2022) (0)
1-Amino-di:methyl-di:pyrido-indole derivs. - useful for treating leukaemia and tumours (1980) (0)
[FORM OF REPLICATION OF EMC VIRUS RNA]. (1963) (0)
Antigenic glycoprotein related to those in the AIDS virus, particularly a precursor of the glycoprotein, and the process to obtain such antigen (1986) (0)
[Tansformation, in gelatinized media, of a diploid strain of human embryonic cells by Rous virus (Schmidt-Ruppin strain)]. (1967) (0)
Nucleotide sequences resulting from the genome of HIV-1, SIV and the retroviruses and their uses for particular apmplifikation of the genomes of these retroviruses and for the in vitro diagnosis of infections caused by these viruses (1990) (0)
Method of antigenic peptide identification and relative use for the preparation of a vaccine anti HIV-1 (2005) (0)
AIDS, hepatitis and hemophilia (2004) (0)
[Isolation of a ribonucleic acid of high molecular weight from 2 different Rous virus strains]. (1965) (0)
Nucleotide sequences of the genome of retroviruses of the type HIV-1, HIV-2 and SIV, and their applications, particularly for the amplification of genomes of retroviruses and for the in vitro diagnosis of infections caused by these viruses (1990) (0)
[Necessity of pure precursors to express a transformation character in BHK 21-13 cells]. (1969) (0)
nucleotide sequences derived from the genome of type retroviruses HIV-1, HIV-2 and SIV, and applications especially for amplification of sequences pol these genomes of retroviruses and for the invitro diagnosis of infections due to these viruses. (1990) (0)
Françoise Barré-Sinoussi and Luc Montagnier share the 2008 Nobel Prize for Physiology and Medicine for their discovery of the human immunodeficiency virus (HIV). (2009) (0)
Two Cases of Kala Azar in Adults. (1939) (0)
Peptides PF11 PF19 has an hiv retrovirus - synthesis process of these peptides - including their use for diagnosis (1988) (0)
Antioxidants and the Regulation of Reactive Iron (1997) (0)
AIDS pathogenesis: Implications for treatment and vaccines (1996) (0)
United States Patent ( 19 ) Montagnier et al . ( 54 ) ANTIBODY DETECTION OF ANTIBODIES (2017) (0)
Pasteur's legacy. (1995) (0)
A method of characterizing a biochemical element having a biological activity, for analyzes of electromagnetic signals of low frequency (2005) (0)
[In the name of Commission VII (Sexually transmissible diseases and AIDS). Heterosexual transmission of HIV in France]. (1995) (0)
PF16 peptides of hiv retrovirus - synthesis process of these peptides - their use for diagnosis (1988) (0)
Cloned dna containing dna insert fragment hybidizable with genomic rna of lymphadenopathyl-associnated virus(lav) (1996) (0)
, L virus-infected individuals . healthy donors or human immunodeficiency activation of peripheral T lymphocytes from In vitro influence of Mycoplasma penetrans on (1995) (0)
Antigen akin to glycoprotein of the AIDS virus, particularly a precursor for glycoprotein, and the procedure for making such antigen (1986) (0)
Cloned DNA sequences hybridizable with genome-rns from "lymphadenopathy-associated virus (LAV)." (1985) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; plenary session transcript; future prospects (1989) (0)
Precursor antigen of hiv-2 human retrovirus envelope protein and antigen having immunologic cognation, and preparation of these antigen and application to diagnosis (1989) (0)
[Chromosomal evolution of a clone of human cells transformed by Rous sarcoma virus]. (1968) (0)
LOSS OF CD4 MEMBRANE EXPRESSION AND CD4 rnRNA DURING ACUTE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BY PATRICK SALMON,* (2003) (0)
MECHANISM OF ACTION OF 2-5A IN INTACT CELLS (1979) (0)
Dipyrido (4,3-b) (3,4-f) indoles, METHOD FOR OBTAINING SAME, therapeutic application and pharmaceutical compositions containing them (1977) (0)
Delivering HIV treatment & care in resource limited settings - Therapeutic mobile units (2012) (0)
Nucleotide sequences of retroviral antigens HIV-1 group (or subgroup) or. (1995) (0)
[Increase, in extracts of cancerous or transformed cells, of protein kinase activity phosphorylating tyrosine]. (1982) (0)
[Perspectives on interferon research and on its therapeutic use]. (1981) (0)
[Transformation of hamster cells by 2 non-defective and defective strains of Rous virus]. (1967) (0)
Evidence for the possible role of a new family of retroviruses in aids (1985) (0)
Role of lymphadenopathy associated virus (LAV) in the pathogenesis of the acquired immunodeficiency syndrome (AIDS) (2005) (0)
To cause of AIDS suitable retrovirus of type HIV-2, as well as its antigen- and nucleic acid constituents. (1987) (0)
Prevalence of anti-nef positive sera in HIV-infected patients: Mapping of the major epitopes of nef-protein using synthetic peptides (1990) (0)
Selective Anergy of + T Cells in Human Immunodetidency Virus-lnfected Individuals (2003) (0)
[Viral etiology of AIDS]. (1986) (0)
Gardasil HPV Vaccination Series [1] (2021) (0)
[AIDS: researchers fight against time. Interview by Robert Henry]. (1988) (0)
Nucleotide sequences derived from the genomes of retroviruses HIV-1, HIV-2 and SIV, as well as their use for amplification of these viral genomes as well as to a vitro diagnosis of infections arising from these viruses (1990) (0)
Peptides characteristics of human immunodeficiency retroviruses (hiv virus) applications in the diagnosis of infections with viruses and some of these, if any, to vaccination against AIDS (1987) (0)
[Supertransformation of a human lymphoblastoid cell line by chemical carcinogens]. (1983) (0)
Cloned dna containing dna insert fragment hybridizable with genomic rna of lav virus (1996) (0)
Variable Course ofPrimary Simian Immunodeficiency VirusInfection inLymphNodes: Relation toDisease Progression (1994) (0)
Dissociation between viral load and neuropathology in the SIV model: Key role of glial cells (1998) (0)
viral vector and recombinant DNA coding for the F protein of the virus causative agent of AIDS, cell culture infected by this vector, method of preparing the protein, protein obtained, vaccine and antibody obtained (1986) (0)
[LAV infections and the acquired immunodeficiency syndrome in infants]. (1986) (0)
Peptides caracteristiques des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida (1987) (0)
Lymphadenopathy-associated huellenantigene and their uses. (1985) (0)
nucleotide sequences of the genome of type retroviruses HIV-1, HIV-2, and SIV and its applications, in particular for amplification of genomes of retroviruses and for the in vitro diagnosis of infections due to these viruses. (1990) (0)
New retrovirus lav-ii type can cause AIDS, antigens obtained from this retrovirus and corresponding antibodies and their applications to diagnosis of AIDS (1986) (0)
Huellenantigene by the human immunodeficiency virus and uses thereof. (1985) (0)
Nucleotide sequences of HIV-1, HIV-2 and SIV retrovirus genomes, their use for amplification of these retroviruses and for the in vitro diagnosis of these viruses infections caused (1990) (0)
Race against time. (1988) (0)
nucleotide sequences derived from the genome of type retroviruses HIV-1 and its applications for amplification of the genomes of retroviruses and for the in vitro diagnosis of infections caused by these viruses. (1990) (0)
Oligonucleotide primers for amplification of the genome of the retrovirus of the HIV-type 1, HIV-2 and SIV, and their applications in vitro diagnosis of infections with these viruses (1989) (0)
Retrovirus associated with lymphadenopathy and adjusts a continuous lineages b lymphoblastoid cells can continuously produce said retrovirus, process for their preparation and application of extracts of these retroviruses in vitro diagnosis of acquired immunodeficiency syndrome or lymphadenopathy (1984) (0)
Pl-Like Adhesin Gene from Mycoplasma pirum (0)
[Correlation between the transformation of BHK 21 cells and their resistance to acid polysaccharides in a gelatinous medium]. (1968) (0)
Vaccine effective component for aids (1994) (0)
Nucleotide sequences of HIV-1, HIV-2 and SIV retrovirus Taken infection to their use for amplification of these retroviruses and for in vitro diagnostic caused by these viruses (1990) (0)
CellSurface Expression ofSeveral Species ofHuman Immunodeficiency VirusType1 MajorCoreProtein (1989) (0)
Method for diagnosing AIDS (1988) (0)
Nucleotide sequences from HIV-1, HIV-2 and SIV-retroviral genomes and their use for mangfoldiggörelse of the pol sequences from these retroviruses and for in vitro diagnosis of infections caused by these viruses (1990) (0)
AIDS Research: An historical survey and perspectives (2004) (0)
Lymphadenopathy Associated Virus (LAV) as the Primary Etiologic Agent of AIDS and Therapeutic Perspectives (1986) (0)
Peptides capable of inhibiting the interactions between viruses and t4 washed cells, products derived therefrom and their applications (1985) (0)
Zidovudine or azidothymidine (2020) (0)
AIDS VACCINES : MONEY GAMES AND ELUSIVE STRATEGIES (2008) (0)
Nucleotide sequences encoding antigens of a retrovirus of the HIV-1 group type o (1994) (0)
Antigens of a transmembrane envelope glycoprotein of a human retrovirus of type HIV-2 and immunologically related antigens (1990) (0)
Multifactorial transformation of human B lymphocytes in vitro (1983) (0)
Interferon Messenger RNA : Translation in Heterologous Cells * ( eukaryotes / mouse / monkey / chick / VERO ) (0)
Antigens encoded by the gag open reading frame (gag open reading frame) of the LAV viruses, their use in the manufacture (1993) (0)

This paper list is powered by the following services:

Other Resources About Luc Montagnier

en.wikipedia.org

What Schools Are Affiliated With Luc Montagnier?

Luc Montagnier is affiliated with the following schools:

Image Attributions

Image Source for Luc Montagnier